Ananthaswamy HN - Search Results

1

Fate of UVB-induced p53 mutations in SKH-hr1 mouse skin after discontinuation of irradiation: relationship to skin cancer development.

Melnikova VO, Pacifico A, Chimenti S, Peris K, Ananthaswamy HN. Melnikova VO, et al. Among authors: ananthaswamy hn. Oncogene. 2005 Oct 27;24(47):7055-63. doi: 10.1038/sj.onc.1208863. Oncogene. 2005. PMID: 16007135

2

Cellular and molecular events leading to the development of skin cancer.

Melnikova VO, Ananthaswamy HN. Melnikova VO, et al. Among authors: ananthaswamy hn. Mutat Res. 2005 Apr 1;571(1-2):91-106. doi: 10.1016/j.mrfmmm.2004.11.015. Mutat Res. 2005. PMID: 15748641 Review.

3

P53 protein and pathogenesis of melanoma and nonmelanoma skin cancer.

Benjamin CL, Melnikova VO, Ananthaswamy HN. Benjamin CL, et al. Among authors: ananthaswamy hn. Adv Exp Med Biol. 2008;624:265-82. doi: 10.1007/978-0-387-77574-6_21. Adv Exp Med Biol. 2008. PMID: 18348463 Review.

4

Mutant p53 is constitutively phosphorylated at Serine 15 in UV-induced mouse skin tumors: involvement of ERK1/2 MAP kinase.

Melnikova VO, Santamaria AB, Bolshakov SV, Ananthaswamy HN. Melnikova VO, et al. Among authors: ananthaswamy hn. Oncogene. 2003 Sep 4;22(38):5958-66. doi: 10.1038/sj.onc.1206595. Oncogene. 2003. PMID: 12955074

5

Genomic alterations in spontaneous and carcinogen-induced murine melanoma cell lines.

Melnikova VO, Bolshakov SV, Walker C, Ananthaswamy HN. Melnikova VO, et al. Among authors: ananthaswamy hn. Oncogene. 2004 Mar 25;23(13):2347-56. doi: 10.1038/sj.onc.1207405. Oncogene. 2004. PMID: 14743208

6

Models and mechanisms in malignant melanoma.

Benjamin CL, Melnikova VO, Ananthaswamy HN. Benjamin CL, et al. Among authors: ananthaswamy hn. Mol Carcinog. 2007 Aug;46(8):671-8. doi: 10.1002/mc.20353. Mol Carcinog. 2007. PMID: 17570501 Review.

7

p53 protects against skin cancer induction by UV-B radiation.

Jiang W, Ananthaswamy HN, Muller HK, Kripke ML. Jiang W, et al. Among authors: ananthaswamy hn. Oncogene. 1999 Jul 22;18(29):4247-53. doi: 10.1038/sj.onc.1202789. Oncogene. 1999. PMID: 10435637

8

Loss of CDKN2A and p14ARF expression occurs frequently in human nonmelanoma skin cancers.

Pacifico A, Goldberg LH, Peris K, Chimenti S, Leone G, Ananthaswamy HN. Pacifico A, et al. Among authors: ananthaswamy hn. Br J Dermatol. 2008 Feb;158(2):291-7. doi: 10.1111/j.1365-2133.2007.08360.x. Epub 2007 Dec 6. Br J Dermatol. 2008. PMID: 18070208

9

Persistence of p53 mutations and resistance of keratinocytes to apoptosis are associated with the increased susceptibility of mice lacking the XPC gene to UV carcinogenesis.

Ananthaswamy HN, Ouhtit A, Evans RL, Gorny A, Khaskina P, Sands AT, Conti CJ. Ananthaswamy HN, et al. Oncogene. 1999 Dec 2;18(51):7395-8. doi: 10.1038/sj.onc.1203147. Oncogene. 1999. PMID: 10602497

10

p53 and the pathogenesis of skin cancer.

Benjamin CL, Ananthaswamy HN. Benjamin CL, et al. Among authors: ananthaswamy hn. Toxicol Appl Pharmacol. 2007 Nov 1;224(3):241-8. doi: 10.1016/j.taap.2006.12.006. Epub 2006 Dec 15. Toxicol Appl Pharmacol. 2007. PMID: 17270229 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

110 results

Search Page